Clinical experience on switching trientine tetrahydrochloride to trientine dihydrochloride in Wilson disease patients.

Autor: Mohr I; Internal Medicine IV, Department of Gastroenterology University Hospital Heidelberg Heidelberg Germany., Schmitt T; Internal Medicine IV, Department of Gastroenterology University Hospital Heidelberg Heidelberg Germany., Weber C; Internal Medicine III, Department of Internal Medicine and Cardiology University Hospital Heidelberg Heidelberg Germany., Schall N; Internal Medicine IV, Department of Gastroenterology University Hospital Heidelberg Heidelberg Germany., Leidner VY; Internal Medicine IV, Department of Gastroenterology University Hospital Heidelberg Heidelberg Germany., Langel A; Internal Medicine IV, Department of Gastroenterology University Hospital Heidelberg Heidelberg Germany., Langel J; Internal Medicine IV, Department of Gastroenterology University Hospital Heidelberg Heidelberg Germany., Poujois A; Department of Neurology, Rothschild Foundation Hospital National reference center for Wilson disease Paris France., Weiss KH; Internal Medicine Salem Hospital Heidelberg Heidelberg Germany., Merle U; Internal Medicine IV, Department of Gastroenterology University Hospital Heidelberg Heidelberg Germany.

Publikováno v: JIMD reports [JIMD Rep] 2024 Sep 17; Vol. 65 (6), pp. 406-416. Date of Electronic Publication: 2024 Sep 17 (Print Publication: 2024).